CANCER GENETICS, INC (51) | Uncategorized (14)

Recent Contracts

Description of Securities (Filed With SEC on March 30, 2022)
Description of Securities (Filed With SEC on March 31, 2021)
Form of Wainwright Warrants dated February 16, 2021 (Filed With SEC on February 16, 2021)
Form of Engagement Agreement, dated September 18, 2020, as amended (Filed With SEC on February 16, 2021)
Form of Placement Agent Warrants (Filed With SEC on February 1, 2021)
At The Market Offering Agreement by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated December 2, 2020 (Filed With SEC on December 3, 2020)
Form of Underwriter Warrants of Cancer Genetics, Inc (Filed With SEC on November 2, 2020)
Description of Securities (Filed With SEC on May 29, 2020)
Standstill Agreement #2, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated May 3, 2019 (Filed With SEC on May 20, 2019)
Standstill Agreement, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated February 12, 2019 (Filed With SEC on April 16, 2019)
Offer Letter with Michael McCartney, dated May 14, 2018 (Filed With SEC on April 16, 2019)
Offer Letter with William Finger, dated December 14, 2018 (Filed With SEC on April 16, 2019)
Form of Placement Agent Warrants of Cancer Genetics, Inc (Filed With SEC on January 29, 2019)
Form of Underwriter Warrants of Cancer Genetics, Inc (Filed With SEC on January 10, 2019)